Incretin-receptor research peptides
Incretin-receptor peptides for laboratory research: Semaglutide, Tirzepatide and Retatrutide, plus related compounds. Research use only.
Incretin-receptor research peptides are tool compounds used in laboratory studies of incretin and glucagon receptor signaling. The category spans three receptor profiles: Semaglutide, a GLP-1 receptor agonist; Tirzepatide, a dual GIP and GLP-1 receptor agonist; and Retatrutide, an agonist of the GIP, GLP-1 and glucagon receptors. USA Warehouse Supply also lists 5-Amino-1MQ and the KLOW Blend in this category. Every product is for research use only.
Questions
How do GLP-1, dual and triple agonist peptides differ?
They differ in which receptors they act on. Semaglutide is a GLP-1 analog with a fatty acid and linker that bind albumin reversibly while it keeps GLP-1 receptor potency. Tirzepatide is a dual GIP and GLP-1 receptor agonist; published pharmacology describes greater engagement of the GIP receptor and, at the GLP-1 receptor, a bias toward cAMP generation over beta-arrestin recruitment. Retatrutide adds the glucagon receptor, acting on GIP, GLP-1 and glucagon receptors.




